What action it is taking to protect young unvaccinated people and those who cannot have the vaccine due to health or age reasons from the r…

The Scottish Government follows the Joint Committee on Vaccination and Immunisation (JCVI) Guidance in developing guidance as the vaccination programme makes progress towards increasing levels of COVID-19 immunity in the population. Current JCVI advice remains that the single greatest risk of mortality and severe disease from COVID-19 is increasing age and COVID-19 risk increases exponentially with age.
Following the recent JCVI advice, young people aged 12 to 15 with severe neuro-disabilities, Down’s Syndrome, immunosuppression and multiple or severe learning disabilities, as well as people who are household contacts of individuals who are immunosuppressed, will be eligible for vaccination soon. The JCVI is not currently advising routine vaccination of children outside of these groups, based on the current evidence.
All young people 16 to 17 years of age will now be offered the coronavirus (COVID-19) vaccination in Scotland. In line with the latest advice from the JCVI, they will be offered a first dose of the Pfizer-BioNTech vaccine. People who are 16 or 17 in mainland Scotland will be invited to register their interest through the online portal at NHS Inform, and will then be sent an appointment via SMS or email. Eligible young people in Shetland, Orkney and Western Isles will be contacted by their health board and invited to attend clinics.
Drop-in clinics are available for 16 to 17-years-olds. Anyone who doesn’t register an interest or attend a drop-in clinic, will be sent an appointment invitation through the post. It is expected that everyone in this age group will have been offered a vaccination appointment by the end of September.
The advice to protect against the risks of contracting COVID-19 or developing any associated ‘Long COVID’ signs and symptoms, remain the same for those who are vaccinated as those unable to receive vaccination for medical reasons. There is further detailed advice available, which is continuously updated in line with protection levels advice, for those who have been shielding for health reasons published here: Coronavirus (COVID-19): shielding advice and support
- gov.scot (www.gov.scot) .
Like all medicines, no vaccine is completely effective, but we do know the vaccination of a high proportion of the population will assist in reducing symptomatic disease and transmission. As the vaccination programme progresses, the Scottish Government advises everyone to follow the protection level rules set for each Local Authority area, as well as to follow general public health guidance issued on non-pharmaceutical measures which help to reduce the spread of COVID-19.
In addition to the individual level of protection against severe disease or hospitalisation afforded by vaccination, a further benefit of the vaccination programme is to assist in developing widespread community immunity and thereby reduce the force of transmission and viral reproduction rate, controlling the prevalence of COVID-19.
Research by Public Health England (PHE), which monitors vaccine efficacy within the UK, shows that those who became infected 3 weeks after receiving one dose of the Pfizer-BioNTech or AstraZeneca vaccine were between 38% and 49% less likely to pass the virus on to their household contacts than those who were unvaccinated. Protection was seen from around 14 days after vaccination, with similar levels of protection regardless of age of cases or contacts. Data is published here: One dose of COVID-19 vaccine can cut household transmission by up to half
- GOV.UK (www.gov.uk) . Further research into the COVID-19 vaccines’ impacts on transmission is underway.
The inoculation of a large proportion of the population will help to provide a degree of ‘passive protection’ in the community for those who cannot receive vaccination for medical reasons and those who may develop a weaker immune response to vaccination due to old age, immunosuppression or illness.